- Record: found
- Abstract: not found
- Article: not found
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
Michael J Mack ,
Martin B Leon ,
Craig R Smith ,
D Craig Miller ,
Jeffrey W Moses ,
E Murat Tuzcu ,
John G Webb ,
Pamela S Douglas ,
William N Anderson ,
Eugene H Blackstone ,
Susheel K Kodali ,
Raj R Makkar ,
Gregory P Fontana ,
Samir Kapadia ,
Joseph Bavaria ,
Rebecca T Hahn ,
Vinod H Thourani ,
Vasilis Babaliaros ,
Augusto Pichard ,
Howard C Herrmann ,
David L Brown ,
Mathew Williams ,
Michael J Davidson ,
Lars G Svensson ,
Jodi Akin
June 2015
June 2015
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality
at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement
(TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic
stenosis. We report here the 5-year outcomes.